Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in Type 1 Diabetes (inTandem2)
NCT02421510Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of sotagliflozin in type 1 diabetes mellitus (T1D), sponsored by Lexicon Pharmaceuticals, Inc.. Started May 2015; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02421510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421510.